VC-backed Blade Therapeutics hires EVP of research
South San Francisco-based Blade Therapeutics, a biopharmaceutical company that treats fibrotic disease, has appointed Dr. Maria E. Fuentes as executive vice president of research. Previously, she was group director of fibrosis discovery biology at Bristol-Myers Squibb. Blade's backers include MPM Capital, Deerfield, Osage Partners, as well as the venture funds of Pfizer, Bristol-Myers Squibb and Novartis.
21 August 2017•3 mins read
